Dr. Bryan Burt
Thoracic Surgeon/Thoracic Surgical Oncologist & Director, General Thoracic Surgery Research
Dr. Bryan Burt is a general thoracic surgeon at Baylor College of Medicine who currently serves as Director of General Thoracic Surgery Research, Associate Professor of Surgery and Interim Chief of General Thoracic Surgery. Dr. Burt previously worked alongside world-renowned mesothelioma expert Dr. David Sugarbaker at Baylor’s Mesothelioma Treatment Center.
Dr. Burt’s clinical practice focuses on a variety of conditions that require thoracic surgery, which he feels can make the biggest impact. When discussing the care he administers to his patients, Dr. Burt states he “feels privileged to care for patients with thoracic cancers and other thoracic surgical problems.” Among Dr. Burt’s highly specialized surgical skills are resectional procedures for malignant pleural mesothelioma and chest wall resection and reconstructions. Treating patients with mesothelioma is of particular interest to Dr. Burt, and as a result, has become a key focus in some of his most recent clinical research endeavors in the laboratory.
Main Specialty: Thoracic Surgery
Other Interests & Specialties: General cardiac/thoracic surgery, thoracic outlet syndrome, lung cancer, esophageal cancer, malignant pleural mesothelioma, esophageal reflux, chest wall tumors, thymic malignancy, minimally invasive video-assisted thoracic surgery (VATS) and open lobectomy.
Certifications, Awards & Accolades: American Board of Surgery Certification in Surgery, American Board of Thoracic Surgery Certification in Cardiac Surgery, Peter Bent Brigham Scholar Award from Brigham & Women’s Hospital, Clarence Coryell Prize in Surgery from Cornell Medical School, Early Career Faculty Award for Excellence in Patient Care from Baylor College of Medicine, American College of Surgeons fellow, Journal of Thoracic and Cardiovascular Surgery (JTCVS) editorial board member, Society of Thoracic Surgeons member, International Thymic Malignancy Interest Group member, American Medical Association member, General Thoracic Biology Club member
- Residency for General Surgery at Brigham and Women's Hospital
- Fellowship for Thoracic Surgery at Brigham and Women's Hospital
- Medical Degree from Weill Cornell Medical College of Cornell University
Soluble Mesothelin-Related Peptides to Monitor Recurrence After Resection of Pleural Mesothelioma. Annals of Thoracic Surgery. November 2017;104(5):1679-1687. doi: 10.1016/j.athoracsur.2017.06.042
Expression of Interleukin-4 Receptor Alpha by Human Pleura Mesothelioma is Associated with Poor Survival and Promotion of Tumor Inflammation. Clinical Cancer Research. March 2012;18(6):1568-77. doi: 10.1158/1078-0432.CCR-11-1808
Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma. Cancer. November 2011;117(22):5234-44. doi: 10.1002/cncr.26143
Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation. Journal of thoracic oncology. November 2018;13(11):1655-1667. doi: 10.1016/j.jtho.2018.08.2036
A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma. Journal of thoracic oncology. September 2018;13(9):1400-1409. doi: 10.1016/j.jtho.2018.04.032
Mesothelioma Clinical Trials by Bryan Burt, MD
Dr. Burt is associated with the following clinical trials:
Conditions: Mesothelioma Last Updated: January 15, 2019 Status: Recruiting